589 Efficacy of oncolytic vaccinia virus requires infection of suppressive immune cells in the tumor microenvironment leading to their reprogramming and deletion

• Greg Delgoffe,
• Paolo Vignali,
• Kristin DePeaux,
• Saumendra Sarkar

Affiliations

Greg Delgoffe

Aff236 grid.21925.3d0000000419369000University of Pittsburgh Pittsburgh PA USA

Paolo Vignali

University of Pittsburgh SOM, Pittsburgh, Pennsylvania, USA

Kristin DePeaux

University of Pittsburgh SOM, Pittsburgh, Pennsylvania, USA

Saumendra Sarkar

University of Pittsburgh, Pittsburgh, PA, USA